Literature DB >> 9198130

The protein C pathway: new insights.

C T Esmon1, W Ding, K Yasuhiro, J M Gu, G Ferrell, L M Regan, D J Stearns-Kurosawa, S Kurosawa, T Mather, Z Laszik, N L Esmon.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9198130

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  12 in total

1.  Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis.

Authors:  M M Boomsma; D J Stearns-Kurosawa; C A Stegeman; E Raschi; P L Meroni; S Kurosawa; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  Heparan sulfate: antithrombotic or not?

Authors:  Jeffrey I Weitz
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

Review 4.  New anticoagulant drugs.

Authors:  J I Weitz
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

5.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Authors:  David T Berg; Bruce Gerlitz; Jing Shang; Tommy Smith; Paula Santa; Mark A Richardson; Ken D Kurz; Brian W Grinnell; Ken Mace; Bryan E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

6.  Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis.

Authors:  Z G Laszik; X J Zhou; G L Ferrell; F G Silva; C T Esmon
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism.

Authors:  John-Bjarne Hansen; José A Fernández; Knut H Borch; John H Griffin; Jan H Brox; Sigrid K Braekkan
Journal:  Thromb Res       Date:  2011-07-20       Impact factor: 3.944

Review 8.  Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.

Authors:  S M Pastores
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 9.  Dysregulation of coagulation in cerebral malaria.

Authors:  Christopher Alan Moxon; Robert Simon Heyderman; Samuel Crocodile Wassmer
Journal:  Mol Biochem Parasitol       Date:  2009-03-26       Impact factor: 1.759

Review 10.  The protein C pathway: implications for the design of the RESPOND study.

Authors:  Burkhard Vangerow; Andrew F Shorr; Duncan Wyncoll; Jonathan Janes; David R Nelson; Konrad Reinhart
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.